Literature DB >> 15342359

Validation of an ultrasensitive and specific immunofluorometric assay for mouse follicle-stimulating hormone.

M Jimenez1, J A Spaliviero, A J Grootenhuis, J Verhagen, C M Allan, D J Handelsman.   

Abstract

Sensitive and specific measurement of FSH is critical to research in reproductive biology, and the increasing availability of transgenic mouse models has created a need for a robust, sensitive, and specific mouse (m) FSH assay. The present study evaluated a time-resolved immunofluorometric assay (IFMA) for mFSH using monoclonal antibody to human (h) FSHbeta as a capture antibody and a biotinylated polyclonal antibody to rat alpha subunit as a detection probe, with signaling amplified by europium-labeled streptavidin. The mFSH IFMA lowered the detection limit 34-fold (5 vs. 170 pg/sample) compared with standard mFSH RIA. The mFSH IFMA demonstrated parallelism of response to dilutions of castrated mouse serum and rat FSH but no cross-reactivity with hFSH and mLH or hLH, whereas the RIA demonstrated nonparallel cross-reactivity with hFSH. The IFMA has a wide analytical range, with a good precision profile for within- and between-assay reproducibility. Because the IFMA is a sandwich-type assay with strict dimer-specificity by design, the lower readings and recovery obtained were compared with the RIA when both assays used a pituitary-purified mFSH assay standard that contained isolated or fragmented subunits as well as intact dimeric FSH. When used with mouse serum sample, the mFSH IFMA demonstrated the expected increases following orchidectomy as well as markedly enhanced sensitivity to very low levels of endogenous mFSH in gonadotropin-deficient mice. Furthermore, the IFMA measured mFSH with fidelity in both intact and orchidectomized male mice without any interference from transgenic hFSH. The greatly enhanced sensitivity, specificity, and technical convenience of this mFSH IFMA will allow wider application of FSH measurements to very small blood samples in immature and mature mice as well as transgenic models.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342359     DOI: 10.1095/biolreprod.104.033654

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  12 in total

1.  Gonadotropins regulate rat testicular tight junctions in vivo.

Authors:  Mark J McCabe; Gerard A Tarulli; Sarah J Meachem; David M Robertson; Peter M Smooker; Peter G Stanton
Journal:  Endocrinology       Date:  2010-03-31       Impact factor: 4.736

2.  Androgen resistance in female mice increases susceptibility to DMBA-induced mammary tumors.

Authors:  Ulla Simanainen; Yan Ru Gao; Kirsty A Walters; Geoff Watson; Reena Desai; Mark Jimenez; David J Handelsman
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

3.  Blocking FSH induces thermogenic adipose tissue and reduces body fat.

Authors:  Peng Liu; Yaoting Ji; Tony Yuen; Elizabeth Rendina-Ruedy; Victoria E DeMambro; Samarth Dhawan; Wahid Abu-Amer; Sudeh Izadmehr; Bin Zhou; Andrew C Shin; Rauf Latif; Priyanthan Thangeswaran; Animesh Gupta; Jianhua Li; Valeria Shnayder; Samuel T Robinson; Yue Eric Yu; Xingjian Zhang; Feiran Yang; Ping Lu; Yu Zhou; Ling-Ling Zhu; Douglas J Oberlin; Terry F Davies; Michaela R Reagan; Aaron Brown; T Rajendra Kumar; Solomon Epstein; Jameel Iqbal; Narayan G Avadhani; Maria I New; Henrik Molina; Jan B van Klinken; Edward X Guo; Christoph Buettner; Shozeb Haider; Zhuan Bian; Li Sun; Clifford J Rosen; Mone Zaidi
Journal:  Nature       Date:  2017-05-24       Impact factor: 49.962

4.  Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo.

Authors:  Ulla Simanainen; Michele Brogley; Yan Ru Gao; Mark Jimenez; D Tim Harwood; David J Handelsman; Diane M Robins
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

5.  Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.

Authors:  Dannielle H Upton; Emily S Fuller; Emily K Colvin; Kirsty A Walters; Mark Jimenez; Reena Desai; David J Handelsman; Viive M Howell; Charles M Allan
Journal:  Horm Cancer       Date:  2015-05-06       Impact factor: 3.869

6.  Temporal role of Sertoli cell androgen receptor expression in spermatogenic development.

Authors:  Rasmani Hazra; Lisa Corcoran; Mat Robson; Kirsten J McTavish; Dannielle Upton; David J Handelsman; Charles M Allan
Journal:  Mol Endocrinol       Date:  2012-11-16

7.  Epitope-specific monoclonal antibodies to FSHβ increase bone mass.

Authors:  Yaoting Ji; Peng Liu; Tony Yuen; Shozeb Haider; Jiahuan He; Raquel Romero; Hao Chen; Madison Bloch; Se-Min Kim; Daria Lizneva; Lubna Munshi; Chunxue Zhou; Ping Lu; Jameel Iqbal; Zhen Cheng; Maria I New; Aaron J Hsueh; Zhuan Bian; Clifford J Rosen; Li Sun; Mone Zaidi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-12       Impact factor: 11.205

8.  Direct action through the sertoli cells is essential for androgen stimulation of spermatogenesis.

Authors:  P J O'Shaughnessy; G Verhoeven; K De Gendt; A Monteiro; M H Abel
Journal:  Endocrinology       Date:  2010-03-12       Impact factor: 4.736

9.  Follicle-stimulating hormone increases bone mass in female mice.

Authors:  Charles M Allan; Robert Kalak; Colin R Dunstan; Kirsten J McTavish; Hong Zhou; David J Handelsman; Markus J Seibel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

10.  Global or Granulosa Cell-Specific Pten Mutations in Combination with Elevated FSH Levels Fail to Cause Ovarian Tumours in Mice.

Authors:  Dannielle H Upton; Kirsty A Walters; Rachel E Allavena; Mark Jimenez; Reena Desai; David J Handelsman; Charles M Allan
Journal:  Horm Cancer       Date:  2016-08-09       Impact factor: 3.869

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.